Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Comment by 1ottrunneron Dec 14, 2021 1:05pm
81 Views
Post# 34229553

RE:RE:RE:RE:Are we getting back to 30s CAD?

RE:RE:RE:RE:Are we getting back to 30s CAD?

The other issue that must be considered is that the data must be BETTER than the competition and that bar has just raised a lot.

I would love to make a million extra pesos on this just like the rest of you but answer me this:
--  Do you really believe that MF has taken this company and speicifically this trial seriously?

I've been in this thing for, my god, has it been 2 years already?  I remember trading at 14 cents, flipping at 26.  I made all my money back then.  I missed the 90 cents, foolishly I thought MF was going to get it done, but I've played this down since the 70's.

And there is nothing wrong with that.

If you aren't atleast a bit negative about the path of this stock, well, I simply can't understand that.

 

PS. I bought shares this morning so I helped pick this up off the 40.5 cent floor. I'll sell them again at 50 cents.


Hydroqc wrote:
Hey runner, nice to hear from you not.
Or should I call you Nostradamouse. Cause just like Nostradamus, your message have to be decoded.

Since I know from other stock board, that you make your due diligence on making research on the stock you invest in, and you don't have time to bother with stock you are not in. And since you think highly of yourself, and the rest of the world are idiots, and in stock exchange, there is winners and idiots.

With that said, I think your prediction is more a wish. A wish, so you can pile up a boat load of  cheap shares.

My advice to this board, is to not let guys like runner dictate his own agenda and fear to you. Make your own diligence and research. The science of Bucillamine is most likely working on paper. The data will eventally confirm it or not.

By the way runner, we are not a year late on data.
Study Completion: December 1, 2021 [Anticipated]

 

<< Previous
Bullboard Posts
Next >>